~~ Hmmmmmm... ~~

"If you are a vaccine company executive, it's time to slam the brakes"

  

(Yes, that above is a click-able link.)

 

"Pfizer's CEO Albert Bourla sees the dangers ahead, as his very carefully worded interview (worthy of close review) with CNBC yesterday shows.".

~

If you want to see all of this post, please click on that click-able link.  Thank you.

~

SOURCE: https://www.cnbc.com/2022/01/10/first-on-cnbc-cnbc-transcript-pfizer-chairman-and-ceo-albert-bourla-speaks-with-cnbcs-squawk-box-today.html

~

To whet your appetite, here is a bit, out of it....

~

"I suspect the smartest people at the companies are increasingly aware of the potential crisis of repeated dosing. Which may be why Bourla also said in the CNBC interview, “I don’t know if there is a need for a fourth booster.”

What? In the same interview where Pfizer’s CEO warned people not to expect long-lasting protection from a third shot - “reasonable right now” - he also pivoted away from more boosters?"  

"Instead Bourla talked up Paxlovid, his company’s new $530 per treatment antiviral. “This is where most of the effort of most of the governments is moving.”"

 ~

Mmmmmm...  Expensive antiviral...   

But, we've had antivirals around for a long time already, and very inexpensive.  

Ahhh, that's right.   

Those were decried as *horse paste.*

But...   

I guess....  

Pfizer's got to make $$$$$$$.  😔

~

~

~

~   ~   ~   ~   ~   ~   ~   ~   ~   ~   ~   ~   ~   ~   ~   ~   ~   ~   ~   ~